Myasthenia gravis lacking response to cholinergic drugs.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001344:Autopsy; D003937:Diagnosis, Differential; D004491:Edrophonium / Q000627:therapeutic use; D004558:Electric Stimulation; D005260:Female; D006801:Humans; D002534:Hypoxia, Brain / Q000150:complications / Q000175:diagnosis*; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D009388:Neostigmine / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use*; D011654:Pulmonary Edema / Q000150:complications; D012131:Respiratory Insufficiency / Q000150:complications; D013945:Thymoma / Q000150:complications / Q000175:diagnosis; D013953:Thymus Neoplasms / Q000150:complications / Q000175:diagnosis; D014403:Tubocurarine / Q000627:therapeutic use; D014459:Ulnar Nerve / Q000503:physiopathology
D010276:Parasympatholytics; D009388:Neostigmine; D004491:Edrophonium; D000324:Adrenocorticotropic Hormone; D014403:Tubocurarine